<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01755403</url>
  </required_header>
  <id_info>
    <org_study_id>CINEBENZ</org_study_id>
    <nct_id>NCT01755403</nct_id>
  </id_info>
  <brief_title>Population Pharmacokinetics in Benznidazole-treated Adults With Chronic With Chagas Disease</brief_title>
  <acronym>CINEBENZ</acronym>
  <official_title>Population Pharmacokinetics in Benznidazole-treated Adults With Chronic Chagas Disease. Benznidazole Pharmacokinetics and Adverse Reactions Relationship.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Barcelona Centre for International Health Research</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Barcelona Centre for International Health Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      o study population pharmacokinetics in Benznidazole-treated adult patients with Chronic&#xD;
      Chagas Disease to get information to optimize drug doses.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Actual">November 2013</completion_date>
  <primary_completion_date type="Actual">November 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Population pharmacokinetic parameters of Benznidazole</measure>
    <time_frame>2 months (treatment period)</time_frame>
    <description>Population pharmacokinetic model development</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse reactions</measure>
    <time_frame>2 months (treatment period)</time_frame>
    <description>Number of participants with adverse events. Severity of adverse events. Relationship between adverse event and drug concentration.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">52</enrollment>
  <condition>Chagas Disease</condition>
  <arm_group>
    <arm_group_label>Benznidazole</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Benznidazole</intervention_name>
    <arm_group_label>Benznidazole</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patients with Chronic Chagas Disease diagnosed by 2 different and positive&#xD;
             serological tests.&#xD;
&#xD;
          -  Patients with Chronic Chagas Disease who are going to start treatment with&#xD;
             Benznidazole.&#xD;
&#xD;
          -  Any gender.&#xD;
&#xD;
          -  All the participants must agree to participate in the study and must sign the informed&#xD;
             consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients younger than 18.&#xD;
&#xD;
          -  Patients with previous hypersensitivity to Benznidazole.&#xD;
&#xD;
          -  Immunocompromised patients as AIDS, cancer, chemotherapy, longterm corticoids need,&#xD;
             primary immunodeficiency, or any other.&#xD;
&#xD;
          -  Hepatic dysfunction&#xD;
&#xD;
          -  Renal dysfunction: serum creatinin higher than 3 mg/dl.&#xD;
&#xD;
          -  Pregnancy or lactation.&#xD;
&#xD;
          -  Low adhesion to treatment or check-up.&#xD;
&#xD;
          -  Impossibility of follow-up.&#xD;
&#xD;
          -  Severe adverse reaction to Benznidazole.&#xD;
&#xD;
          -  Any other situation that could be risky for the patient.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joaquim Gascón, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Barcelona Centre for International Health Research (CRESIB)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>International Health Department, Hospital Clinic, Barcelona</name>
      <address>
        <city>Barcelona</city>
        <state>Cataluña</state>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <study_first_submitted>December 19, 2012</study_first_submitted>
  <study_first_submitted_qc>December 19, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 24, 2012</study_first_posted>
  <last_update_submitted>May 25, 2015</last_update_submitted>
  <last_update_submitted_qc>May 25, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 27, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chagas Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Benzonidazole</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

